Research Output per year
Research Output
2020
KMT2A rearranged acute lymphoblastic leukaemia: Unravelling the genomic complexity and heterogeneity of this high-risk disease
Forgione, M. O., McClure, B. J., Eadie, L. N., Yeung, D. T. & White, D. L., 28 Jan 2020, In : Cancer Letters.Research output: Contribution to journal › Short survey
3
Citations
(Scopus)
2018
Precision medicine approaches may be the future for CRLF2 rearranged Down Syndrome Acute Lymphoblastic Leukaemia patients
Page, E. C., Heatley, S., Yeung, D., Thomas, P. & White, D., 28 Sep 2018, In : Cancer Letters. 432, p. 69-74 6 p.Research output: Contribution to journal › Short survey
1
Citation
(Scopus)
2017
First Approved Kinase Inhibitor for AML
Rasko, J. E. J. & Hughes, T., 16 Nov 2017, In : Cell. 171, 5, 1 p.Research output: Contribution to journal › Short survey
6
Citations
(Scopus)
Targeted therapies: Remembrance of things past - Discontinuation of second-generation TKI therapy for CML
Hughes, T. & Ross, D. M., 1 Apr 2017, In : Nature Reviews Clinical Oncology. 14, 4, p. 201-202 2 p.Research output: Contribution to journal › Short survey
4
Citations
(Scopus)
2015
Phenotype switching in melanoma: Implications for progression and therapy
Li, F. Z., Dhillon, A. S., Anderson, R. L., McArthur, G. & Ferrao, P. T., 1 Jan 2015, In : Frontiers in Oncology. 5, FEB, 31.Research output: Contribution to journal › Short survey
Open Access
72
Citations
(Scopus)
2013
Li-gazing at the crest: Modulation of the neural crest by the ubiquitin pathway
Wiszniak, S., Lumb, R., Kabbara, S., Scherer, M. & Schwarz, Q., 1 Jan 2013, In : International Journal of Biochemistry and Cell Biology. 45, 6, p. 1087-1091 5 p.Research output: Contribution to journal › Short survey
3
Citations
(Scopus)
Too much of a good thing
Onodera, A., Tumes, D. & Nakayama, T., 1 Feb 2013, In : Nature Immunology. 14, 2, p. 112-114 3 p.Research output: Contribution to journal › Short survey
1
Citation
(Scopus)
2011
"Capacity building"Eine aufgabe der akademischen welt
Research output: Contribution to journal › Short survey
2009
The therapeutic applications of multipotential mesenchymal/stromal stem cells in skeletal tissue repair
Arthur, A., Zannettino, A. & Gronthos, S., 1 Feb 2009, In : Journal of Cellular Physiology. 218, 2, p. 237-245 9 p.Research output: Contribution to journal › Short survey
252
Citations
(Scopus)
2008
Home Is Where the Heart Is: Via the FROUNT
Zannettino, A. C. W., Psaltis, P. J. & Gronthos, S., 5 Jun 2008, In : Cell Stem Cell. 2, 6, p. 513-514 2 p.Research output: Contribution to journal › Short survey
Is drug treatment superior to allografting as first-line therapy in chronic myeloid leukemia? Commentary
Hughes, T., 1 Jan 2008, In : Nature Clinical Practice Oncology. 5, 1, p. 14-15 2 p.Research output: Contribution to journal › Short survey
1
Citation
(Scopus)
The contribution of different androgen receptor domains to receptor dimerization and signaling
Centenera, M. M., Harris, J. M., Tilley, W. D. & Butler, L. M., Nov 2008, In : Molecular Endocrinology. 22, 11, p. 2373-2382 10 p.Research output: Contribution to journal › Short survey
93
Citations
(Scopus)
2005
Inhibition of c-fms by imatinib: Expanding the spectrum of treatment
Dewar, A. L., Zannettino, A. C. W., Hughes, T. P. & Lyons, A. B., 1 Jan 2005, In : Cell Cycle. 4, 7, p. 851-853 3 p.Research output: Contribution to journal › Short survey
45
Citations
(Scopus)
2004
Cancer treatment with kinase inhibitors: What have we learnt from imatinib?
Ross, D. M. & Hughes, T., 12 Jan 2004, In : British Journal of Cancer. 90, 1, p. 12-19 8 p.Research output: Contribution to journal › Short survey
35
Citations
(Scopus)
1996
How HIV leads to neurological disease
Brew, B. J., Wesselingh, S. L., Gonzales, M., Heyes, M. P. & Price, R. W., 19 Feb 1996, In : Medical Journal of Australia. 164, 4, p. 233-234 2 p.Research output: Contribution to journal › Short survey
10
Citations
(Scopus)